Psoriatic arthritis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 12: | Line 12: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Arthritis]] | [[Category:Arthritis]] | ||
[[Category:Autoimmune diseases]] | [[Category:Autoimmune diseases]] | ||
[[Category:Rheumatology]] | [[Category:Rheumatology]] | ||
Revision as of 18:33, 14 May 2018
|
Psoriatic arthritis Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Psoriatic arthritis secondary prevention On the Web | |
|
American Roentgen Ray Society Images of Psoriatic arthritis secondary prevention | |
|
Risk calculators and risk factors for Psoriatic arthritis secondary prevention | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chandrakala Yannam, MD [2]
Overview
There are no established secondary preventive measures for psoriatic arthritis.
Secondary prevention
- There are no established secondary preventive measures for psoriatic arthritis.
- Patients are monitored regularly for disease activity, drug efficacy, adverse effects and associated comorbid conditions.[1]
References
- ↑ Gladman DD, Helliwell P, Mease PJ, Nash P, Ritchlin C, Taylor W (January 2004). "Assessment of patients with psoriatic arthritis: a review of currently available measures". Arthritis Rheum. 50 (1): 24–35. doi:10.1002/art.11417. PMID 14730596.